Siemens Healthineers AG

Siemens Healthineers AG

48.26
USD
-0.25
(-0.52%)
2.27EPS
19.95P/E
50.09BMarket Cap
Feb 04Next Earn

Total Valuation

USD

As of September 30, 2026, Siemens Healthineers AG carries a market capitalization of 50.09B, placing it among publicly traded companies globally. Its enterprise value stands at 47.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap50.09B
Enterprise Value47.80B

Important Dates

Siemens Healthineers AG's next confirmed earnings release is scheduled for February 4, 2027.

Earnings Date2/4/2027

Share Statistics

As of September 30, 2026, Siemens Healthineers AG has 1.12B shares outstanding.

Shares Outstanding1.12B

Valuation Ratios

As of September 30, 2026, Siemens Healthineers AG trades at a trailing price-to-earnings ratio of 19.95. The price-to-sales ratio is 1.87, and the price-to-book ratio stands at 2.23.

PE Ratio19.95
PS Ratio1.87
PB Ratio2.23
P/TBV Ratio-10.78
P/FCF Ratio18.05
P/OCF Ratio13.43

Enterprise Valuation

As of September 30, 2026, Siemens Healthineers AG trades at an EV/EBITDA multiple of 9.62 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.78 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 13.19 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Siemens Healthineers AG trades at an EV/FCF ratio of 15.26, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 47.80B versus a market cap of 50.09B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.78
EV / EBITDA9.62
EV / EBIT13.19
EV / FCF15.26

Financial Position

As of September 30, 2026, Siemens Healthineers AG maintains a current ratio of 1.18, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.35, indicating elevated leverage, while an interest coverage ratio of 10.74 demonstrates strong ability to service its debt obligations.

Current Ratio1.18
Quick Ratio0.22
Debt / Equity4.35
Debt / EBITDA0.20
Interest Coverage10.74

Financial Efficiency

USD

These figures cover the twelve months ended September 30, 2026. The company generates approximately 361,190.47 in revenue per employee across its workforce of 74,150.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.37 indicates how many times Siemens Healthineers AG sells and replaces its inventory over a year, a key working capital efficiency ratio.

Revenue Per Employee361,190.47
Employee Count74,150.00
Inventory Turnover3.37

Taxes

USD

Over the twelve months ended September 30, 2026, Siemens Healthineers AG recorded 732.18M in income tax expense. That works out to an effective tax rate of 22.36, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.27B, leaving 2.51B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax732.18M
Effective Tax Rate22.36

Stock Price Statistics

USD

As of the close on November 16, 2026, Siemens Healthineers AG's stock has declined approximately 6.38% over the past 52 weeks. The 50-day moving average sits at 46.15, while the 200-day moving average is 44.50.

52-Week Price Change-6.38%
50-Day Moving Average46.15
200-Day Moving Average44.50

Income Statement

USD

Over the twelve months ended September 30, 2026, Siemens Healthineers AG generated 26.78B in revenue and converted that into 2.51B in net income, yielding earnings per share of 2.27. EBITDA reached 4.97B, while operating income came in at 3.62B.

Revenue26.78B
Gross Profit10.33B
Operating Income3.62B
Pretax Income3.27B
Net Income2.51B
EBITDA4.97B
EBIT3.62B
Earnings Per Share (EPS)2.27

Balance Sheet

USD

As of September 30, 2026, Siemens Healthineers AG holds 3.35B in cash and equivalents against 981.53M in total debt, resulting in a net debt position of -2.88B. Total book value stands at 22.50B, with working capital of 2.76B providing operational flexibility.

Cash & Cash Equivalents3.35B
Total Debt981.53M
Net Debt-2.88B
Equity (Book Value)22.50B
Book Value Per Share20.10
Working Capital2.76B

Cash Flow

USD

Siemens Healthineers AG produced 3.73B in operating cash flow over the twelve months ended September 30, 2026. After subtracting -954.32M in capital expenditures, free cash flow totaled 2.77B - equivalent to 2.48 per share.

Operating Cash Flow3.73B
Capital Expenditures-954.32M
Free Cash Flow2.77B
FCF Per Share2.48

Margins

Over the twelve months ended September 30, 2026, Siemens Healthineers AG posted a gross margin of 38.57, reflecting its pricing power and cost economics. The operating margin of 13.53 and net profit margin of 9.37 provide insight into operational efficiency.

Gross Margin38.57
Operating Margin13.53
Pretax Margin12.23
Profit Margin9.37
EBITDA Margin18.55

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 5.54, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 4.75, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Siemens Healthineers AG shareholders.

Shareholder Yield4.75
FCF Yield5.54

Scores

As of September 30, 2026, Siemens Healthineers AG has an Altman Z-Score of 2.89, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.89